Your browser doesn't support javascript.
loading
Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine.
Lothert, Keven; Offersgaard, Anna F; Pihl, Anne F; Mathiesen, Christian K; Jensen, Tanja B; Alzua, Garazi Peña; Fahnøe, Ulrik; Bukh, Jens; Gottwein, Judith M; Wolff, Michael W.
Afiliação
  • Lothert K; Institute of Bioprocess Engineering and Pharmaceutical Technology, Department of Life Science Engineering, University of Applied Sciences Mittelhessen (THM), Giessen, Germany.
  • Offersgaard AF; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Pihl AF; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mathiesen CK; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Jensen TB; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Alzua GP; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Fahnøe U; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Bukh J; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Gottwein JM; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. jgottwein@sund.ku.dk.
  • Wolff MW; Institute of Bioprocess Engineering and Pharmaceutical Technology, Department of Life Science Engineering, University of Applied Sciences Mittelhessen (THM), Giessen, Germany. michael.wolff@lse.thm.de.
Sci Rep ; 10(1): 16261, 2020 10 01.
Article em En | MEDLINE | ID: mdl-33004836
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Vacinas contra Hepatite Viral / Hepacivirus Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Vacinas contra Hepatite Viral / Hepacivirus Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha